Peter Mac Research

Congrats to A/Prof @shomgoel, has today been awarded the Gottschalk Medal from @Science_Academy! His research is reshaping how we treat and understand #breastcancer. A huge honour and well deserved. 👏 🔗 petermac.org/about-us/news-…

We’re #hiring 2 researchers to join exciting, multi-disciplinary programs within our Dawson labs.  These roles are responsible for analysing large-scale data, applying best-practice bioinformatics workflows & developing innovative new methods. More: petermac.org/careers

Peter Mac trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma. 💊 Standard chemo + new drug glofitamab ✅ 98% complete response 🔒 86% progression-free at ~2 years 📈 92% overall survival MORE: petermac.org/about-us/news-…

Peter Mac’s Prof @MAF_Dawson has won the 2025 @ASH_hematology William Dameshek Prize – the first Australian to receive this top honour for his world-leading work in epigenetics. More: petermac.org/about-us/news-…

Ground-breaking, practice-changing research from Prof Danny Rischin & Prof Sandro Porceddu @PeterMacCC and brilliant team of 🌏investigators. 👏 Excellent results for patients with high-risk SCC of skin, presented at #ASCO25 @ASCO Full results @NEJM ➡️ nejm.org/doi/full/10.10…

A record number of Peter Mac researchers presented at #ASCO25 — with global-impact trials, theranostics leadership, ctDNA breakthroughs & more. 🌍 “Our presence is getting bigger and more impactful each year.” – Prof Jayesh Desai. Read more: petermac.org/about-us/news-…

An experimental therapy involving radioactive Terbium, and designed to seek out and kill prostate cancer cells wherever they are in the body, has shown very positive initial results in a first-in-human clinical trial at Peter Mac. Read more: petermac.org/about-us/news-…

Don't miss the first-in-human VIOLET study being presented #ASCO25 @ASCO Monday June 2 3:00 PM New Frontiers in Prostate-Specific Membrane Antigen Radioligand Therapy (awesome research being presented in this session - don't miss the other talks) In press @TheLancetOncol…

More practice changing research coming out of @PeterMacCC presented @ASCO2025. With a simultaneous publication in @NEJM 🙌 dailynews.ascopubs.org/do/c-post-adju…

Applications are now open for this unique opportunity to undertake a 2-year clinical fellowship based between two world leading centres, @TheChristieNHS in the UK and @PeterMacCC in Australia. Find out more and apply: healthjobsuk.com/job/v7234944

Australia completely lacks a dedicated training program for clinician scientists. With the vision and support of VMIAL @PeterMacCC is extremely proud to announce the first clinician-scientist fellowship. If you meet the eligibility criteria PLEASE APPLY! nature.com/naturecareers/…

An electric first day at the 2025 #PeterMacResearch Symposium ⚡ 400+ scientists & clinicians gathered to explore Future Tech & Patient-Centred Innovations. A powerful mix of collaboration, curiosity & cutting-edge thinking. 🧵 Highlights below 👇

He's done it!! Gamini cycled 5000kms over 42 days - crossing the entire continent from Perth to Brisbane. Crossing the finish line on election day, he raised over $21K for cancer research at Peter Mac. Read more about this incredible feat: petermac.org/about-us/news-…

With a grant from the @MarkHughesFdn, @PeterMacRadOnc's Dr Neda Haghighi will explore if using three smaller pre-surgery doses of radiotherapy (rather than one) can lead to better outcomes & less impact on quality of life in secondary brain cancer. More:newcastle.edu.au/newsroom/featu…

Congratulations to @DrMHofman on winning the prestigious @TheRACP Eric Susman Prize for transforming prostate cancer care through theranostics – combining precision imaging with targeted radiation. 🔗 racp.edu.au/news-and-event… #ProstateCancer #Theranostics #EricSusmanPrize

We are seeking a clinical trial co-ordinator who wants to make a true impact... at @PeterMacCC . you’ll lead the coordination of our @pros_tic clinical trials, building on more than a decade of global leadership in cutting-edge research. Why Join Us? ⦿ Global Recognition: We…

Targeting #GDF-15 in cancer: Recent, early-phase trials show positive effects on two very challenging aspects of cancer care — #immunotherapy response and #cachexia symptoms. Read the News & Views from Jayesh Desai & colleagues @PeterMacCC nature.com/articles/s4159…

Dr Louise Kostos (@LouiseKostos) shares her view on long-term toxicity associated with combination therapies in locally advanced and metastatic hormone-sensitive prostate cancer. #mHSPC #pcsm urologytimes.com/view/an-expert…

Two Peter Mac research projects have received funding from the OCRF to drive next-gen #ovariancancer breakthroughs. Congrats to @DrDaleGarsed, A/Prof @kylie_gorringe, and their teams! Read more: petermac.org/about-us/news-…

Australian National AML Clinical Guidelines now available! Expert-driven, evidence-based treatment recommendations from the Australian haematology community to support informed decisions & improve patient outcomes. 🔗 hsanz.org.au/AML-Guidelines #AML #Haematology #BloodCancer